Protalix BioTherapeutics Reports Third Quarter 2021 Financial Results and Provides Financial and Business Update
- Monday, November 15, 2021, 7:01
- Finance
- Add a comment
CARMIEL, Israel, Nov. 15, 2021 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant…
About the Author
adminasapcorp has written 41790 stories on this site.